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ABSTRACT 
Robbins Miller, Kelly.  M.S., Department of Biological Sciences, Wright State 
University, 2007.  Investigation of Interactions between Rev and Microtubules: 
Purification of Wild-type and Mutant Rev Protein and Optimization of Microtubule 
Depolymerization Assays. 
 
 
 
  As a logical pharmaceutical target for antiviral drugs, HIV-1 Rev is a regulatory 
protein essential for viral infection (Hope, 1999).  The development of antiviral drugs 
that target Rev has been hindered by the lack of high-resolution structural information 
due to the protein’s tendency to aggregate in solution.  While searching for solution 
conditions rendering Rev amenable to crystallographic analyses, Watts et al., (2000) 
discovered a novel in vitro interaction between Rev and microtubules (MTs) whereby 
addition of equimolar Rev and tubulin forms bilayered rings called Rev-tubulin toroidal 
complexes (RTTs).  RTTs are similar to those seen when MTs are mixed with certain 
anti-MT drugs and KinI kinesins (Watts et al., 2000).  Coupled with the sequence 
homology that exists between KinI kinesins and Rev, I hypothesize that Rev and KinI’s 
are depolymerizing MTs by a shared mechanism.  This mechanism may include the 
binding of the Rev/KinI to the end of the MT inducing a curved confirmation in the MT 
thereby destabilizing it to promote depolymerization.   
I propose to test this hypothesis through measuring Rev-MT interactions by 
adapting biochemical and microscopy-based assays used to measure MT 
depolymerization by KinI proteins.  These assays require microgram amounts of highly 
purified wild-type and mutant Rev proteins as well as purified tubulin from which MTs 
can be polymerized in vitro.  To this end, I have purified wild type Rev with no visible 
contaminants on coomasie stained gels.  Rev mutants R42A and E57A can also be 
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purified with limited visible contaminants.  However, the appropriate controls can be 
generated from non-expressing cells to address this issue.  Rev mutants A37D and R39A 
can also be partially purified. 
Using purified Rev proteins, I then applied sedimentation assays to measure Rev-
stimulated MT depolymerization.  There was a statistically significant time dependence 
for wild type Rev to depolymerize MTs although there was no evidence for concentration 
dependence.  Visual assays demonstrate no significant difference in the length of MTs 
treated with Rev although Rev decreased the number of MTs on the coverslip over time.  
This could contribute to the finding that MT depolymerization by Rev is time dependent. 
These results demonstrate that it is possible to measure Rev-MT interactions in 
vitro although it is clear that these assays are deficient in certain ways, including the 
ability of MTs to depolymerize on their own and RTTs potentially pelleting during the 
depolymerization assay.  However, it is likely that cycling tubulin and/or using taxol to 
further stabilize the MTs can remedy the deficiency of MT depolymerization on their 
own.  EM could also be used to determine if RTTs are pelleting during the 
depolymerization assay. 
After using mutant Rev proteins in the depolymerization and visual assays, it is 
the long-term goal that mechanistic information about Rev will lend valuable evidence to 
the study of KinI kinesins.   Generating structural Rev information may also be helpful in 
the drug design of anti-mitotic peptides.   
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Introduction  
Rev is an essential 116 amino acid regulatory protein that is expressed early 
during infection and is essential for human immunodeficiency virus (HIV) replication 
(Hope, 1999).  Without Rev, there is no production of Pol, Env, and Gag, proteins 
encoded by underspliced RNAs that are necessary for virion production.  Overexpression 
of Rev has been indicated to cause general structural deformity within cells, and 
accumulation of cells that have failed cytokinesis, suggesting slowing of cell cycle 
progression (Miyazaki et al., 1995).  Multiple studies have identified the mechanism by 
which Rev functions (Malim et al. 1998, reviewed by Hope, 1999 and Pollard et al., 
1998).  Immediately after its translation, Rev is imported into the nucleus where it binds a 
stem-loop structure unique to an intron of viral RNAs called RRE (Rev Response 
Element).  Multiple Rev monomers multimerize on the RRE which subsequently 
promotes nuclear export of these RNA’s to the cytoplasm allowing translation of Pol, 
Env, and Gag proteins.  
Rev’s Functional Domains 
 
Mutational analysis initiated by Malim et al. (1989) (reviewed by Hope, 1989 and 
Pollard and Malim, 1998) has identified four functional domains of Rev responsible for 
nuclear import, RRE binding, multimerization, and nuclear export.  They systematically 
mutated every charged residue and potential phosphorylation site and overexpressed each 
in COS cells.  They identified a nuclear localization signal (NLS) defined by mutants M5 
and M6 where Rev localizes more in the cytoplasm than the nucleus (Figure 1).  Both 
mutations are placed in an arginine-rich region of Rev, which interacts with importin β, a 
nuclear transport factor shown to mediate Rev import in digitonin permeabilized cells 
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(Truant and Cullen, 1999).  Both M5 and M6 mutants are also deficient in RRE binding.  
RRE binding is mediated by both interaction with the phosphate backbone and specific 
nucleotides (reviewed by Hope, 1999 and Pollard et al., 1998; Daly et al, 1990; Heaphy 
et al., 1991).  The competition of the RRE and importin β for this arginine-rich region is 
thought to prevent re-import of Rev before it has released RRE-containing transcripts in 
the cytoplasm (Hope, 1999). 
There are two multimerization domains in Rev defined by M4 and M7 mutants 
(Figure 1) (Malim et al., 1989).  Rev multimerization is typically monitored using gel 
retardation assays that measure the formation of high-order protein complexes formed in 
labeled RRE.  Measurement of binding affinities for monomer, dimer, trimer for the RRE 
indicate that both Rev M4 and M7 form multimeric complexes more poorly than wild-
type Rev.  A comparison of monomer and multimer binding affinities for M4 suggest that 
this mutant is truly deficient in multimerization.  In contrast, Rev M7 can readily form 
multimers although it is deficient in binding the initial monomer (Brice et al., 1999).  The 
deletions of the two amino acids in Rev M7 may be more responsible for protein folding 
that multimerization.   
There is a nuclear export sequence (NES) present in wild-type Rev that promotes 
export of viral mRNA out of the nucleus into the cytoplasm.  Mutational analysis has 
confirmed that mutant M10 residues are part of the NES of Rev (Malim et al., 1989, 
Figure 1), which binds the nuclear export factor Crm1 (Truant and Cullen, 1999).  Unlike 
previous mutations that are recessive, the M10 mutant is a trans-dominant inhibitor of 
wild-type Rev function (Malim et al., 1989).  M10 expression reduces the levels of late, 
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structural gene expression following infection of HIV virus.  Moreover, M10 expression 
does not support provirus production in Rev deficient cells (Malim et al., 1989).   
Rev is required for virion production and the transdominance exhibited by M10 
demonstrates that Rev is a potential protein target for HIV-1 drug therapy.  Clearly, 
structural data about Rev would facilitate drug design; however, there exists only limited 
high-resolution structural information about Rev due to its high tendency to aggregate in 
solution.  Circular dichroism (CD) spectra have indicated that approximately half of the 
Rev sequence has a helical secondary structure (Wingfield et al. 1991; Daly et al., 1990).  
CD spectra on Rev mutants with deletions from amino acids 68-112 or 92-112 suggest 
that these helical structures are on the N-terminal part of the protein (Auer et al., 1994).  
Blanco et al. (2001) have used solid state NMR to confirm this helix-loop-helix model in 
full length Rev protein.  They propose a helix-loop-helix model where residues 8-26 form 
an N-terminal α-helix that interacts with a second helix formed by amino acids 34-59.  
Thomas et al. (1998) suggest that hydrophobic residues present in each helix tether the 
two together.   
In vitro, Rev persists as monomers, dimers, multimers, non-physiological 
filaments, and non-functional aggregates in a concentration dependent manner (Wingfield 
et al., 1991; Blanco et al., 2001).  Rev is dimeric at 0.1 mg/ml, and forms increasing 
multimers at concentrations reaching 1 mg/ml (Wingfield et al., 1991).  Rev can, 
however, be kept in its monomeric form when denatured with 6M urea or stored in high 
salt (>750 mM) (Wingfield et al., 1991; Karn et al., (1995).  In more physiological 
conditions, Rev forms filaments at increasing temperatures above freezing and 
concentration (1-2 mg/ml), and aggregates follow when stored in sodium phosphate 
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buffer (Wingfield et al., 1991).  However, solvation conditions that prevent filament 
aggregation have been determined (Watts et al., 1998).  After overexpression and 
purification of Rev (Wingfield et al., 1991), Rev can be unfolded in 6 M urea and 
refolded by sequentially dialyzed against first, ammonium sulfate, and second, sodium 
citrate as described in Materials and Methods (Watts et al., 1998).  Rev filaments are 
stored at 4ºC in the third dialysis buffer.  Although these filaments are probably not the 
physiologically relevant form of Rev, they retain their functionality.   
While searching for solution conditions required to provide more structural 
information about Rev, Watts et al., (2000) discovered a novel interaction between Rev 
and microtubules (MTs).  Since previous experiments indicated that Rev exhibits high 
affinity binding with RNA, poly G, poly dG, and polyglutamate and that these polyanions 
can depolymerize Rev filaments in vitro (Heaphy et al., 1991; Wingfield et al., 1991; 
Watts et al., 1998), Watts et al. reasoned that tubulin may prevent nonspecific 
aggregation of Rev allowing X-ray crystallography.  Alpha and beta tubulin are acidic 
proteins and their 3D structures have been solved with X-ray crystallography (Nogales, et 
al., 1998) to reveal highly acidic C-termini that may interact with Rev’s basic residues.  
They speculated that Rev might bind the acidic C-termini of tubulin while the bulk of 
tubulin may block higher order aggregation.   
Upon the addition of equimolar amounts of Rev-filaments to tubulin monomers, 
electron microscopy reveals immediate formation of Rev tubulin toroidal complexes 
(RTTs) or rings (Watts et al. 2000).  RTTs have a mass of approximately 3-4 MD and 28, 
30, and 32 fold symmetry (Watts et al., 2000).  When MTs are added in molar excess, the 
MT ends appear curled and RTTs are seen forming.  The depolymerization of MTs by 
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Rev and appearance of RTTs occurs by a method that is typical of MTs in cells and those 
treated with MT destabilizing drugs like the anti-cancer drug Dolastatin (Watts et al., 
2000).  Interestingly, Maytansine, another anti-cancer drug whose binding site is the 
same as Dolastatin, blocks the formation of the RTTs, indicating that Rev may bind at or 
near the vinca binding site of β-tubulin (Watts et al., 2000).  Taxol and colchicine, MT 
drugs that bind to different sites on tubulin, do not block ring formation suggesting that 
Rev binds tubulin specifically.  RTTs also form in the presence of Rev and tubulin 
heterodimer suggesting that RTTs form in the presence of polymerized and 
depolymerized tubulin (Watts et al., 2000). 
The specificity of Rev for MTs is further suggested by the findings that RTT 
formation occurs in the presence of 200 mM NaCl and at 4°C and 25°C (Watts et al., 
2000).  At 500 mM NaCl both Rev filaments and MTs are depolymerized.  Rev/MT 
interactions appear to be more complex than simple electrostatic interactions because 
RTT formation is resistant to changes in pH (6-8).  Furthermore, ringed structures are not 
produced when MTs are mixed with other basic proteins including histones, lysozyme, 
polylysines, and polyarginines (Watts et al., 2000).  Ring formation is also noticed with 
GDP-tubulin and MTs mixed with KinI kinesins and certain MT destabilizing drugs like 
Dolastatin-10 (Watts et al., 2000). 
A molecular explanation of Rev/MT interactions is suggested by a statistically 
significant sequence similarity between Rev and XKCM1, a microtubule destabilizing 
protein found in Xenopus eggs (Watts et al., 2000) (Figure 2).  XKCM1 is a member of 
the KinI class (recently named Kinesin 13 (Lawrence et al., 2004)) within the Kinesin 
super family of proteins.  Most kinesins are microtubule motor proteins that translocate 
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along MT surfaces.  Unlike conventional kinesins, KinI kinesins bind to MTs and 
promote MT catastrophes, events that reverse MT polymerization and promote rapid 
depolymerization.  XKCM1’s KinI homologs include MCAK (hamster mitotic 
centromere associated kinesin),  Kif2c (mouse), and pKinI (P. falciparum).  The 
Rev/XKCM1 sequence similarity is conserved in these homologs (Figure 2).  
Furthermore, pKinI has been shown to bind and destabilize MTs producing rings 
(Moores et al., 2002).     
In cells, XKCM1 and its homologs are crucial participants in spindle disassembly 
and MT dynamics.  (Kline-Smith & C. E. Walczak, 2002).  Inhibiting XKCM1 in 
prophase PtK2 cells by microinjecting inhibitory anti-XKCM1 antibody causes a 
decrease in the catastrophe frequencies of MTs, resulting in long MTs that disrupt spindle 
assembly and mitotic delay or arrest (Kline-Smith & C.E. Walczak, 2002).  The mitotic 
spindle has dynamic properties, and a recent study indicated that some of these dynamic 
properties could be reconstituted by mixing tubulin with the XKCM1 and the stabilizing 
microtubule associated protein XMAP215 (Becker et al., 2002).  This experiment implies 
that there is a balance of destabilizing and stabilizing factors that regulate spindle 
dynamics with XKCM1 being at least one component.  Rev may also be a catastrophe 
promoter that depolymerizes MTs to produce tubulin rings, or inhibit rescue of MTs.  
Rev, like XKCM1, causes disassembly of MTs from both ends (Watts et al., 2000).  
Mechanism of KinI-mediated MT depolymerization 
 
Much is known about how KinI kinesins bind and depolymerize MTs.  Moores 
and colleagues (2002) supported that the N-terminal domain of KinI’s mediates 
localization to the centromere; the C-terminal domain is required for dimerization of the 
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KinI although monomers are functional (Maney et al., 1998; Hertzer et al., 2006), and 
that these properties can be completely separated from the KinI internal motor domain 
necessary for depolymerization activity.  The “neck” domain, a region adjacent to the 
motor domain (head), confers directionality and motor processivity in motile kinesins 
(Case et al., 1997; Henhingsen and Schliwa, 1997; Endow and Waligora, 1998; Romberg 
et al., 1998).  The neck itself does not possess depolymerizing activity for MCAK 
(XKCM1 human homologue) (Maney et al., 2001).  The neck region may be important in 
stabilizing the interaction between the KinI and the MT, and not necessarily required for 
depolymerization.  The “neckless” KIF2C can bind to the side-wall of MTs but 
depolymerization activity is weak (Ogawa et al., 2004).  A “neckless” pKinI, MCAK, 
and KIF2C exhibit some depolymerization activity; however, the depolymerization is 
enhanced 5-fold with the addition of the neck region (Ovechkina et al., 2002; Maney et 
al., 2001; Moores et al., 2002; Ogawa et al., 2004). 
There are three other regions in XKCM1 within the motor domain that are unique 
to KinI proteins and may therefore play a role in binding and depolymerization of MT’s: 
(1) the Tu-C Loop, (2) the Lys/Arg Loop, and (3) the L11-α4 helix-L12 region of the 
catalytic domain (Rev homology region) (Figure 3).  
(1) The Tu-C Loop (L2) is a positively charged chain of amino acids that is 
predicted to lie near the negatively charged C-terminus of tubulin (Niederstrasser et al., 
2002).  This loop contains a cluster of class specific residues known as the “KVD finger” 
(Ogawa et al., 2004; Shipley et al., 2004).  This finger is thought to lie next to the MT 
surface, and when mutated depolymerization activity is greatly reduced (Ogawa et al., 
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2004; Shipley et al., 2004).  The KVD finger was indicated to not be involved in MT 
binding, but plays an important role in MT depolymerization (Ogawa et al., 2004).   
(2) The Lys/Arg Loop (L8) might affect the affinity of XKCM1 to tubulin or 
contribute to the destabilization of the MT lattice.  It may serve as a sensor for ATP 
hydrolysis at the end of the MT  (Ogawa et al., 2004; Shipley et al., 2004).  When the 
KinI reaches the end of the MT and loses ADP, the switch II cluster (L11-α4) makes 
contact with the MT, and L8 along with loop 12 are possible anchor points on the MT 
around the switch II domain (Ogawa et al., 2004; Shipley et al., 2004).  L8 may then be 
involved in the tugging and bending of the tubulin protofilament underneath (Ogawa et 
al., 2004; Shipley et al., 2004).  As a result of the curved conformation of tubulin, ATP 
hydrolysis is triggered.   
(3) The atomic structure of the L11-α4 helix-L12 region is not known for 
XKCM1, but using structural information available for Kif1a, a motile kinesin, and Kif2c 
to model XKCM1-MT interaction, the shared domain of XKCM1 and Rev may consist of 
a long α-helix that may bind the MTs in the space between the α and β-tubulin subunits 
(highlighted in Figure 3) (Niederstrasser et al., 2002; Woehlke et al., 1997).  It is the 
main MT binding region for Kif2c (Ogawa et al., 2004).  When the Kif2c makes full 
contact with the MT, the α4 helix is inserted in the intradimer grove (Ogawa et al., 2004).    
Shipley et al. (2004) presented a 1.6 angstrom crystal structure of pKinI motor 
core with no nucleotide present.  Mutated residues R242A (in L11), R272A (in α4), 
KEC268,269,270AAA (in α4) indicated reduced binding and ATPase activity, with the 
KEC mutant indicating almost no depolymerization activity (Shipley et al., 2004).  The 
R272 and KEC residues are indicated to be adjacent to the intradimer interface of the α/β-
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tubulin heterodimer, and play an essential role in pKinI/MT interaction (Shipley et al., 
2004).  EM images showed that the KEC mutant barely decorated the MT, indicating that 
MT binding was reduced, and R272 indicated similar results (Shipley et al., 2004).  
R242A, however, can still bind the MT although to a lesser extent, but may play a greater 
role in ATP hydrolysis (Shipley et al., 2004).  XKCM1 contains the KEC domain, and 
Rev has a homologous E amino acid at the same position.  In XKCM1, when the E of the 
KEC mutant is mutated, XKCM1 is depolymerization deficient (M. Miller, personal 
communication).  This residue may prove essential to the Rev/MT interaction.  The L11-
α4 helix-L12 region is important in both MT binding and depolymerization with the α4 
helix region being more involved in binding. 
There is a precise curvature of the pKinI-AMPPNP-tubulin ring produced by 
depolymerization of MTs by pKinI’s.  Through contour mapping and gray scale imaging, 
the pKinI motor appeared to sit in a more centered position with respect to the tubulin 
dimer than does motile KinN protein (Moores et al., 2002).  There seemed to be a 
deformation of the tubulin ring as a result of the binding AMPPNP.  Due to the fact that 
this ring conformation was not noticed in other stabilized MTs under the same 
experimental conditions, Moores et al. (2002) proposed that the pKinI binding is entirely 
responsible for the bent tubulin conformation. 
Ogawa et al. (2004) proposed a model of MT depolymerization using 
crystallographic data of Kif2c (a KinI) bound to ATP or ADP.  They propose that Kif2c 
binds at the end of the MT, making full contact with the protofilament by injecting its α4 
helix (Rev homology region) into the intradimer groove.  Creating a curved tubulin 
confirmation, the other regions of the KinI (neck and TuC Loop) bind to the MT and 
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stabilize the curved conformation, destabilizing the lateral interaction.  Then more KinI’s 
bind to the curved protofilament, which changes MT dynamics enough to cause 
depolymerization (Ogawa et al., 2004) (Figure 3).   
There is also a proposed mechanism for MT depolymerization by KinI Kinesins 
(Shipley et al., 2004; Niederstrasser et al., 2002; Moores et al., 2002).  The KinI reaches 
the end of the MT by lattice diffusion (Helenius et al., 2006; Hunter et al., 2003) and 
exchanges its ADP nucleotide.  Then, ATP binding at the β-tubulin tail causes a 
conformational change; this results in a bent confirmation of the tubulin dimer.  Due to 
the curved tubulin conformation, the tubulin dimer is released from the protofilament, 
and hydrolysis of ATP is triggered.  After ATP hydrolysis, the KinI dissociates and is 
free to bind to another MT (Helenius et al., 2006).  Although Rev is not using ATP 
hydrolysis to depolymerize MTs, there is still useful information obtained from the 
consideration of KinI’s. 
Comparison of depolymerizing activities of Rev and KinI proteins (Table 1) 
 
The motor core is highly conserved among the kinesin superfamily (Ogawa et al., 
2004), and in KinI kinesins is responsible for MT depolymerization.  The pKinI motor 
core appeared to sit in the middle to the tubulin subunits (Shipley et al, 2004; 
Niederstrasser et al., 2002; Moores et al., 2002; Ogawa et al., 2004), which is important 
due to the similarity of this motor core with Rev activity.  Kinesins are ATPases that 
undergo nucleotide-dependent conformational changes (Moores et al., 2002).  Since Rev 
does not bind nucleotide, Rev is unlikely to mimic the nucleotide-dependent 
conformational changes achieved by KinI proteins.  However, KinI-mediated MT 
depolymerization is not dependent on ATP hydrolysis (Moores et al., 2002).  When 
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pKinI motor core is added to MTs, depolymerization of the MT occurs in the presence of 
ATP or AMPPNP (non-hydrolysable ATP).  By using other nucleotide analogs to mimic 
the different states of the ATPase cycle and taxol-stabilized MTs, Moores et al. (2002) 
and Niederstrasser et al., (2002) demonstrated that ATP binding to the KinI motor core 
was needed for MT depolymerization, but not hydrolysis.  They also established that the 
C-terminal tail of tubulin is essential for KinI depolymerization, as depolymerization did 
not occur with subtilisin-treated MTs.  However, Helenius et al. (2006) showed that the 
decrease in depolymerization of subtilisin-treated MTs by KinIs is due to the decrease in 
end targeting caused by the lack of C-terminal-tail-mediated diffusion along the MT.  In 
addition, Moores et al. (2002) and Niederstrasser et al. (2002) demonstrated that the β-
tubulin C-terminus is essential for depolymerization.  However, Rev has been indicated 
to still depolymerize subtilisin-cleaved MTs, lending support to the argument that the 
Rev/MT interaction is more specific than an electrostatic interaction (Watts et al., 2000).         
Specific Aims 
 
Due to their sequence similarity and shared ringed-intermediates during 
depolymerization, it is hypothesized that Rev binds and depolymerizes MTs by a 
mechanism similar to that of the KinI kinesins.  The long term goal is to demonstrate 
which Rev residues are important for KinI activity by mutating residues to inhibit Rev’s 
ability to bind and/or depolymerize MTs in vitro.  To test this hypothesis, the following 
point mutations have been placed in Rev: T34A, A37D, R39A, R42A, E47A, R50A, 
E57A, and E47A/E57A.  To address the hypothesis, the following aims must be 
addressed:   
Aim 1) Express Wild-type and mutant Rev proteins in E.coli and purify.   
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Aim 2) Purify tubulin. 
Aim 3) Complete MT depolymerization/binding assays to compare the 
depolymerization/binding ability of wild-type Rev versus mutants.   
Expected Results 
 
Basic Residues (R39, R42, R50) 
 
 Rev’s basic residues may be important since they are likely to bind the acidic MT 
residues.  The Rev residues R39A and R42A are highly conserved among KinI’s (Ogawa 
et al., 2004).  Both R39A and R42A are also involved in binding the RRE and, therefore, 
should be accessible for MT binding.  Rev R50A is predicted to be close to the 
MT/kinesin interface, as indicated by the homologous residues highlighted on the Kif2c 
crystal structure (Figure 4).  This residue lies in between the M6 and M7 mutants, 
responsible for RNA binding and multimerization of Rev, therefore, also accessible for 
MT binding.  Consequently, limited MT depolymerization activity as compared to wild 
type Rev is expected because of reduced binding of these basic residue mutants to the 
MT during the MT binding assay.  
Acidic Residues (E47, E57) 
Rev’s acidic residues are expected to be more important during MT 
depolymerization than binding.  The Rev E57A residue is found in all KinI’s and may be 
the most important residue for depolymerization activity (Shipley et al., 2004; Ogawa et 
al., 2004).  In Rev, E57 appears one amino acid before the M7 mutant, which is 
responsible for Rev structure and multimerization and considered accessible for MT 
binding.  The E in the KEC mutant of the pKinI aligns with E57 (Shipley et al., 2004).  
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This residue mutated in XKCM1 was indicated to have markedly reduced 
depolymerization activity (unpublished data, Dr. Mill Miller).   
Rev E47A is common to most KinI’s (Ogawa et al., 2004).  It appears three 
amino acids after M6, which is responsible for RNA binding.  This acidic residue may be 
partly responsible for destabilizing the MT’s in order to depolymerize them similar to 
E57A.  The E47A/E57A mutant combines the activity of both the acidic residues in Rev.   
Reduced Priority Residues (T34, A37) 
 
Rev T34A residue is conserved among the KinI’s (Ogawa et al., 2004).  T34 is 
found near the M5 mutant, which has a role in RNA binding.  Therefore, I expect this 
mutant to have reduced MT binding versus wild type Rev, and should have less MT 
depolymerization activity versus wild type Rev due to its inability to bind the MT.   
Rev A37D is conserved in most KinI’s (Ogawa et al., 2004).   A37 is near Rev’s 
multimerization domain.  I expect this mutant to bind the MT similar to that seen with 
wild type Rev binding assay.  However, I expect multimerization to be important to MT 
depolymerization by Rev, so this mutant should indicate reduced depolymerization 
activity as compared to wild type Rev.  In XKCM1, the homologous residue to A37D has 
been mutated and had no effect on depolymerization activity of XKCM1 (K. Hertzer & 
C.E. Walczak). 
To test the hypothesis that Rev will bind and depolymerize MT’s in a mechanism 
similar to KinI’s, wild-type Rev and mutants will first be expressed, purified, and re-
folded in an active state.  Then binding and depolymerization assays capable of 
measuring their ability to bind and depolymerize MTs in vitro need to be validated.  This 
data will not only provide structural information about Rev, but due to the sequence 
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similarity with KinI kinesins, this information may also provide insights into which 
residues are necessary for KinI kinesin depolymerization of MTs, which could aid in 
further mechanistic discovery of MT depolymerization by KinI’s.   
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Materials and Methods 
 
Protein Expression / Large Scale Cultures 
 The wild-type Rev gene was previously ligated into the pET11d vector (Blanco et 
al., 2001).  Wild-type and mutant Rev constructs are perpetuated in DH5α cells 
(Sambrook et al., 1989).  For protein expression, pET-Rev constructs were transformed 
into chemically competent BL21 (DE-3) cells (Invitrogen).  Transformed cells were 
grown and selected on LB plates with 100 µg/ml ampicillin overnight at 37˚C.  One 
transformed colony was used to inoculate a 10 ml LB broth-100 µg/ml ampicillin.  This 
culture, incubated at 37ºC overnight with 250 rpm shaking, was used to inoculate a 1 L 
LB-100 µg/ml ampicillin culture.  When cell density reached the log growth phase (OD 
≈0.6), IPTG (isopropyl-β-D-thiogalactopyranoside) was added to a final concentration of 
1 mM.  Cells were collected 2 hours later by centrifugation at 10,000 rpm (SS-34 rotor) 
for 10 minutes and stored at -20ºC. 
FPLC: Rev Purification 
Method 1, Karn et al., (1995) 
 
Frozen cells were lysed by sonication, 3 times for 30 seconds, in 11 ml buffer A 
(400 mM sodium chloride, 50 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 
pH 8.0) per 1 L culture.  Sonicates were frozen and thawed and sonicated as before.  
Sonicates were clarified by 10,000 rpm for 10 minutes in a SS-34 rotor.  The supernatant 
was applied to a Q-sepharose column (HiPrep QXK16).  After eluting with 2 column 
volumes of buffer A, Rev was eluted with buffer B (800 mM sodium chloride, 50 mM 
Tris-HCl, 1 mM EDTA, 1 mM DTT, pH 8.0) and applied to a Heparin-sepharose column 
(HiPrep Heparin Sepharose 6FF).  After the column was washed with Buffer C (1 M 
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sodium chloride, 50 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, pH 8.0) such that the 
optical density of the eluant was background, Rev was eluted with buffer D (2 M sodium 
chloride, 50 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, pH 8.0).  Aliquots of Q-sepharose 
and Heparin-sepharose columns were resolved by SDS-PAGE and detected by coomassie 
staining.   
Protein concentration was determined using Fuji Multigauge software and the 
coomassie stained SDS-PAGE gels mentioned above before refolding.  All aliquots 
containing Rev were pooled and denatured in 6M urea, and refolded properly by 
sequential dialysis steps in dialysis buffers 1-3 overnight as described by Watts et al. 
(1998).  Dialysis buffer 1 contained 50 mM sodium phosphate, 600 mM ammonium 
sulfate, 150 mM sodium chloride, 50 mM sodium citrate, 1 mM EDTA, pH 7.0.  Dialysis 
buffer 2 contained 50 mM sodium phosphate, 150 mM sodium chloride, 50 mM sodium 
citrate, 1 mM EDTA, pH 7.0.  Dialysis buffer 3 contained 20 mM Hepes, 100 mM 
sodium chloride, 50 mM sodium citrate, 1 mM EDTA, pH 7.0, and also served as the 
storage buffer for Rev at 4˚C.  Rev is refolded into filaments and stored in this form. 
Method 2, Wingfield et al., (1991) 
 
Mutant proteins that did not purify well with Method 1 were purified by Method 
2.  Cell pellets from 1 L cultures were resuspended in 11 ml of buffer E (100 mM Tris-
HCl, 5 mM DTT, 5 mM EDTA, 5 mM benzamide, 1 mM PMSF, pH 8.0) and sonicated 
as above.  Sonicates were clarified by centrifugation at 10,000 rpm for 10 min. as above.  
The supernatant was centrifuged at 60,000 x g for 1 hour in an SW-27 rotor.  The 
supernatant was diluted 3-fold with buffer F (50 mM Tris-HCl, 1 mM sodium azide, pH 
8.0) and applied to the Q-sepharose column equilibrated with buffer F.  Select fractions 
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from the Q-sepharose column were dot-blotted using 3 µl from each fraction, and 
developed using polyclonal Rev antibody.  The flow-through fractions containing Rev 
were collected, pooled and denatured with the addition of urea to 6 M.  This extract was 
diluted 2-fold with buffer G (20 mM sodium phosphate, 2 M urea, 1 mM DTT, 1 mM 
EDTA, pH 6.5), and the pH was adjusted to 6.5 using H3PO4.  The solution was then 
applied to the Heparin-sepharose column equilibrated with buffer G and when the 
baseline absorption was zero, Rev was eluted with a linear gradient of buffer G + 1 M 
NaCl with Rev eluting at approximately 0.5 M NaCl.  SDS-PAGE gels of aliquots from 
Q-sepharose and Heparin-sepharose fractions were coomassie stained.  Rev containing 
fractions were pooled and denatured in 6 M urea and dialyzed as described above. 
Tubulin Purification 
 
 Tubulin was purified from bovine brain (http://mitchison.med.harvard.edu/ 
protocols/tubprep.html).  Three brains supplied by Copey’s Butcher Shop (Medway, 
Ohio) were transported to the lab in a cooler with 3 L pre-cooled 1.5% NaCl and 1 large 
bag of ice.  The meninges were stripped at 4ºC and brains homogenized with PB (Pipes 
Buffer, 0.1 M Pipes, pH 6.8, 0.5 mM MgCl2 2 mM EGTA, 0.1 mM EDTA, 0.1% B-ME, 
1 mM ATP) to 1.75 L.  The homogenate was spun at 22,680 x g for 75 minutes at 4˚C in 
a GSA/SS-34 rotor.  570 ml supernatant was supplemented with 50% volume of glycerol 
warmed to 37˚C, ATP to 1.5 mM, GTP to 0.1 mM, and MgCl2 to 3.5 mM.  Extracts were 
swirled to mix incubated at 37ºC for 60 minutes, and subjected to centrifugation in a 
Type 50.2 Ti rotor at 13,000 rpm for 160 minutes.    
Recovered pellets were placed on ice and resuspended in 20 ml of cold PB, 1 mM 
ATP and 0.1% 2-mercaptoethanol.  Pellets were homogenized using a dounce 
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homogenizer and placed on ice for 40 min.  Extracts were subjected to centrifugation 
using a Type 50.2 Ti rotor at 42,000 rpm for 30 minutes at 4ºC.   
The supernatants were recovered and supplemented with 50% volume of pre-
warmed glycerol, GTP to 0.5 mM, and MgCl2 to 4 mM.  The supernatant was incubated 
at 37ºC for 40 minutes and spun in a Type 50.2 Ti rotor at 47,000 rpm for 30 minutes at 
37ºC.  Recovered pellets were resuspended in ice-cold 50 ml of CB (Column Buffer, 50 
mM Pipes, pH 6.8, 0.5 mM MgCl2, 2 mM EGTA, 0.1 mM EDTA, 0.1 % B-ME, 1 mM 
ATP) using a dounce homogenizer.  After incubation at 4˚ C for 40 min., the sample was 
spun in a Type 50.2 Ti rotor at 42,000 rpm for 30 minutes.   
The supernatant was applied to a phosphocellulose column (PC) (approximately 
200 ml volume) equilibrated with CB.  The flow rate was set at 2 ml/min, and 3 ml 
fractions were collected.  Bradford assays were performed and fractions that indicated 
greater than 1 mg/ml tubulin were collected and combined (fractions 36-60, 125 ml).  The 
final concentration was determined spectrophotometrically (ε280 = 115,000 M
-1cm-1) to 
yield 125 ml of 14.2 µM tubulin. 
The column was washed with three volumes of 1 M KCl in CB to elute the 
microtubule associated proteins (MAPs).  MAPs eluted after 200 ml of 1 M KCl in CB 
were added, and fractions greater than 1 mg/ml were collected.  The MAPs were frozen 
in liquid nitrogen and stored at –80˚C.  The column was equilibrated with 10 volumes of 
CB + 0.1% NaN3 for storage. 
Tubulin Cycling 
 Two 7 ml aliquots of phosphocellulose purified (PC) tubulin were thawed on ice 
and cold water.  Aliquots were supplemented with 5X BRB80, 1M MgCl2, and 100 mM 
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GTP to final concentrations of 0.5X, 4 mM, and 1 mM, respectively.  The tubulin mixture 
was incubated on ice for 5 minutes, and then shifted to 37ºC for 2 minutes.  Ten percent 
(1.4 ml) DMSO was added to the tubulin mixture and this was incubated at 37ºC for 40 
minutes.  A 60% glycerol cushion containing 1.6 ml 5X BRB80, 12 ml 100% glycerol, 
and 6.4 ml sterile water was added in 10 ml aliquots to two 50.2Ti rotor tubes.  The 
tubulin mixture was layered on top of the cushion and spun at 50K, 35ºC for 35 minutes.   
 The pellets were washed twice with 1X IB (10X IB contains 500 mM K+ 
glutamate, 50 mM MgCl2, pH 7.0 with KOH), resuspended in 500 µl of ice cold 1X IB 
using an 18 g needle and incubated 30 min. on ice.  Sample was then subjected to 
centrifugation at 2ºC for 90K for 15 minutes in the Sorvall, 30° fixed angle, Beckman 
type 50.2 Ti pre-cooled rotor.  The supernatant was collected, aliquoted, and frozen at -
80ºC.  The concentration of tubulin was determined spectrophotometrically as above. 
MT Depolymerization Assay 
 Cycled tubulin was polymerized at 37ºC for 30 minutes in the presence of 10 mM 
GMPcPP and BRB80/DTT (1X BRB80, 1 mM DTT) and collected by centrifugation 
(TLA100 at 35ºC, 90K, for 5 minutes).  The pellets were resuspended in 20 µl of 
BRB80/DTT at room temperature.  The tubulin concentration was determined 
spectrophotometrically as above.  The microtubule stock was diluted to 3 µM with 
BRB80/DTT.  Rev protein was diluted to concentrations ranging from 50 nM to 3 µM 
with Dialysis Buffer 3.  Rev protein is stored in the filamentous form, and becomes 
partially oligomeric and monomeric during the assay when the concentration is lowered. 
 The reactions were set up so that the total volume of each reaction was 40 µl.  
Four microliters of Rev protein were added to 16 µl BRB80/DTT and 20 µl of 3 µM MTs 
 
 20
were added last.  The reactions occurred within 1.5 ml eppendorf tubes at room 
temperature (22ºC).  After 10 minutes, 20 µl of each reaction was removed and spun 
down in a TLA100 rotor at 22ºC for 5 min at 90,000 rpm.  The remaining 20 µl of each 
reaction were removed and spun down in the same manner 20 minutes from MT addition.  
The supernatants were collected and added directly to 20 µl of 2X SDS-PAGE sample 
buffer and boiled.  Twenty microliters of 2X SDS-PAGE sample buffer was added 
directly to the pellet and resuspended, then 20 µl of BRB80/DTT was added and the 
pellet sample boiled.  All samples were resolved on a 15% SDS-PAGE gel and coomasie 
stained or transferred and a western blot was performed. 
Visual MT Binding Assay 
 Cycled tubulin was polymerized at 37ºC for 30 minutes in the presence of 10 mM 
GMPcPP and BRB80/DTT (200 µl 5X BRB80, 2 µl 0.5 M DTT, 796 µl dH20) and 
collected by centrifugation (TLA100 at 35ºC, 90K, for 5 minutes).  The pellets were 
resuspended in 20 µl of BRB80/DTT at room temperature.  The tubulin concentration 
was determined spectrophotometrically as above.  The microtubule stock was diluted to 3 
µM with BRB80/DTT.  Rev protein was diluted to 125 nM in dialysis buffer 3.   
 Four non-stress fractured chocks were added to each spin down tube (Kimble HS, 
No.45500-15), and then a poly-L-lysine coated coverslip was added to each tube.  5 ml of 
1X BRB80 was added to each spin down tube and they were balanced.  2 µl 5X BRB80, 
0.6 µl KCl, 1.4 µl H20, 5 µl 3 µM MTs and 1 µl 125 nM Rev protein were added together 
and incubated at room temperature for 15 min.  Each spin down tube was underlain with 
2 ml BRB80/10% glycerol.  Three microliters of reaction mixture was fixed with 30 µl 
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BRB80/1% paraformaldehyde.  Each reaction was then diluted with 800 µl BRB80, 
mixed gently by inversion, and 50 µl was placed on top of BRB80 in spin down tube. 
 Reactions were sedimented for 70 min at 8,000 rpm (10,000 x g) in an HB4 rotor 
at 20˚C.  The coverslips were post fixed with -20˚C methanol for 5 minutes, and then 
placed in TBS-T.  Coverslips were then moved to a Petri dish, washed with TBS-T (8.8g 
NaCl, 0.2g KCl, 3g Tris, 500 µL Tween-20, dH20 to 1L, pH 7.4) three times, and 
immunostained.  After blocking with 75 µl 2% BSA/TBS-T, coverslips were incubated 
for 30 min. in 20 µl of Monoclonal Anti-α-Tubulin Clone DM1A (1:5000) and Sheep 
anti-HIV-1 Rev (1:500).  Coverslips were washed 1 time (short wash for 20 seconds) and 
then 2 times (long washes for 1 minute) with TBS-T, and then incubated for 30 min. in 
30 µl of Fluorescein (FITC)-conjugated Donkey Anti-Sheep IgG (1:500) and Rhodamine 
(TRITC)-conjugated Goat Anti-Mouse (1:500) in 2%BSA/TBS-T.  The coverslips were 
washed as above, and mounted on slides using 1.5 µl Vectashield, sealed with nail polish, 
and examined.  The slides were stored at 4˚C.  
 Alternatively, after fixing the reaction mixtures, 50 µl of the reaction mixture 
were spotted directly onto coverslips and incubated for 4-6 hours.  The reaction mixture 
was removed and coverslips were washed once with TBS-T.  The coverslips were then 
post-fixed with –20 °C methanol for 5 minutes and then placed in TBS-T.  Coverslips 
were immunostained and stored as indicated above.   
Statistical Analyses 
 
 Dr. DeAnne C. French, Statistical Consultant at the Wright State University 
Statistical Consulting Center, completed all analyses with SPSS v. 15.0.1.    
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Results 
Rev Purification (Specific Aim 1) 
 If biochemical assays previously used to study KinI proteins are to be used to 
study Rev/MT interactions, then large amounts of purified, biologically active proteins 
are required.  Previous studies have shown that recombinant Rev expressed in E.coli is 
biologically active (Karn et al., 1995; Brice et al., 1999; Watts et al., 1998, 2000; 
Wingfield et al., 1991).  Using the pET11 vector where the Rev gene is under control of 
the lac promoter (Blanco et al., 2001), preliminary experiments indicated that the two-
hour treatment of log phase cultures with 1 mM IPTG gave optimal expression of full 
length Rev with minimal accumulation of truncated Rev (data not shown). 
Initial purification of Rev followed the procedures by Karn et al. (1995) owing to 
the availability of chromatographic equipment.  Cells are sonicated, and clarified by low 
speed centrifugation.  The supernatant, containing Rev, is sequentially chromatographed 
over Q-sepharose and Heparin-sepharose columns.  Rev binds the positively charged Q-
sepharose column indirectly through Rev’s interaction with nucleic acids that bind to the 
column.  After eluting Rev with 800 mM NaCl, Rev is bound to the negatively charged 
Heparin-sepharose column.  After washing the column with 1 M NaCl, Rev is eluted with 
2 M NaCl.  Purified Rev is then refolded through sequential dialysis steps described in 
“Materials and Methods.”   
Typical results of the purification of wild-type Rev are represented in Figure 4.  
Rev co-elutes with a single peak of proteins released from the Q-sepharose column by 
800mM NaCl (Figure 4 A/B).  It elutes from Heparin-sepharose column as a pure protein 
in a single peak (Figure 4 C/D).  Purified Rev is refolded and dialyzed, indicated in 
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Figure 4 E.  This procedure yields 1-1.5 mg of total protein per liter culture at 
concentrations ranging from 1-1.7 mg/ml.   
 Rev R42A was also purified using this method.  Rev R42A co-elutes with a single 
peak of proteins released from the Q-sepharose column by 800 mM NaCl (Figure 5 A/B).  
It is important to note that a large amount of Rev R42A that does not bind the Q-
sepharose column.  This is most likely due to the decreased affinity of this mutant to 
nucleic acids, as this residue is present in the region that mediates RRE binding (Malim et 
al., 1989).  Rev R42A then co-elutes with a single peak of proteins released from the 
Heparin-sepharose column by 2 M NaCl (Figure 5 C/D).  This mutant protein is not as 
pure as WT Rev as indicated by coomasie stained SDS-PAGE (compare Figures 4 E and 
5 E).   
 Attempts to purify additional mutants Rev E57A, Rev R39A, and Rev A37D 
using this method failed.  In each instance, Rev did not bind the Q-sepharose column 
(Figure 6).  The inability of Rev E57A to bind the Q-sepharose column may be due to a 
structural change in the protein from this mutation, as this residue lies at the end of the 
multimerization domain and is considered a structurally important amino acid (Brice et 
al., 1999).    E57A is so close to the RNA binding domain (residues 35-50) may change 
the folding of Rev, and not present the arginine residues needed for RRE binding (Brice 
et al., 1999).  Rev R39A is located in the ARM (arginine rich motif), this region contains 
the RNA binding domain and a mutation in this domain reduces the proteins ability to 
bind nucleic acids.  Rev A37D is located near the RNA binding domain, however A37 is 
not thought to be important for RNA binding, but this residue is thought to lie in a 
hydrophobic patch that hold helix 1 and helix 2 together (Thomas et al., 1998).     
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These failures necessitated a need for a second purification scheme.  To this end, 
the methods of Wingfield et al. (1991) were adapted to the available FPLC columns.  
Designated as Method 2, is the method that uses an anion exchange column to separate 
nucleic acids from Rev.  The former binds the Q-sepharose column whereas Rev does 
not.  Since most of the mutant Rev is found in the flow through fractions, this method is 
chosen.   
Results of the purification of wild-type Rev through Method 2 are represented in 
Figure 7.  Rev co-elutes with a single peak of proteins in the flow through of the Q-
sepharose column (Figure 7 A/B).  Approximately half of the wild-type Rev binds to the 
Q-sepharose column, although this is discarded in the second peak (Figure 7 A/B).  Once 
the flow through is denatured with 6 M urea and diluted to 4 M urea, it is 
chromatographed over the Heparin-sepharose column.  Wild-type Rev then elutes with a 
single peak of proteins released from the Heparin-sepharose column by 1M NaCl and 4 
M urea (Figure 7 C/D).  Wild-type Rev is re-folded through sequential dialysis steps. 
 Results of the purification of Rev E57A through Method 2 are represented in 
Figure 8.  Rev E57A primarily co-elutes with a single peak of proteins in the flow 
through of the Q-sepharose column (Figure 8 A/B), although 20% or less of Rev E57A is 
bound to the column and discarded (Figure 8 A/B). The remaining flow-through fractions 
containing Rev E57A are pooled and denatured with 6 M urea, diluted to 4 M urea, and 
then chromatographed over the Heparin-sepharose column.  Rev E57A then co-elutes 
with other proteins in a single peak released from the Heparin-column by 1 M NaCl and 4 
M urea (Figure 8 C/D).  An additional 10% or less of Rev E57A is lost in the flow 
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through on the Heparin-sepharose column (Figure 8 C, Peak 11-15).  Rev E57A is re-
folded through sequential dialysis steps (Figure 8 E).   
The disadvantage of this method is that the protein is not as pure as that purified 
by Method 1 (compare Figure 4 E vs. 8 E).  Whether these contaminants will affect Revs 
ability to bind and/or depolymerize MTs is not clear.  To generate appropriate negative 
controls for the MT assays, BL21 cellular proteins were subjected to Method 2 
purification.  Figure 9 shows the negative control obtained from Method 2 purification.  
There were no visible proteins on a coomasie stained SDS-PAGE gel after the Heparin-
sepharose column; therefore, to obtain a negative control for Method 2, the flow-through 
fractions were pooled after the Q-sepharose column.  The proteins visible on a coomassie 
stained SDS-PAGE gels (Figure 9) are similar to the contaminating proteins in Figure 8 
E, although, there are more proteins present in the negative control. 
Tubulin Purification (Specific Aim 2) 
 Tubulin was purified from bovine brain as described in Materials and Methods.  
Briefly, tubulin was sequentially polymerized, depolymerized, and centrifuged 
repeatedly, then passed over a phosphocellulose column to separate it from the MAPs.  
Tubulin was collected and stored at -80ºC.  The concentration of tubulin, 14.2 µM, is 
much lower than the expected 227 µM tubulin (http://mitchison.med.harvard.edu/ 
protocols/tubprep.html).  Purified tubulin resolved by coomasie stained SDS-PAGE is 
represented in Figure 10.  MAPs were also eluted from the column and stored at -80ºC. 
MT Depolymerization Assay (Specific Aim 3) 
 Previous assays showing that Rev binds and depolymerizes MTs have relied on 
TEM.  To study the biochemical properties of the Rev/MT interaction, assays used to 
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measure the KinI/MT interaction might be adapted to study Rev’s mode of action.  Now 
that the proteins are purified, assays capable of testing Rev’s ability to bind and 
depolymerize MTs needs to be optimized.      
 One common assay, described in Materials and Methods, measures the amount of 
tubulin released from MT polymers following addition of a depolymerizing agent 
(Niederstrasser et al., 2002; Moores et al., 2002; Moores et al., 2004; Desai et al., 2001).  
In brief, polymerized MTs are incubated with wild type or mutant Rev for various time 
periods.  Then the reaction mixture is subjected to high-speed centrifugation to separate 
MTs from liberated tubulin heterodimers.  The supernatant and pellet are resolved by 
SDS-PAGE and the percentage tubulin released into supernatants is determined.   
There are several variables to be considered during the optimization of the 
depolymerization assay.  First, the assay has to be completed with tubulin alone.  As a 
positive control, tubulin should stay in the pelleted fraction until a depolymerizing agent 
is added to the reaction mixture.  Second, completing the assay with Rev alone will help 
indicate depolymerization because Rev that does not sediment to the pellet should be 
greater with MTs in the reaction mixture than with Rev alone.  Third, the molar ratio of 
Rev to tubulin will provide information about the concentration dependence of MT 
depolymerization by Rev.  Fourth, a time dependence of MT depolymerization by Rev 
has to be considered. 
MTs need to be demonstrated not to depolymerize on their own in order to 
indicate that there is an interaction with Rev that causes the MTs to depolymerize.  When 
3 µM MT’s are used alone in the depolymerization assay, a range from 30-50 percent of 
tubulin ends up in the supernatant over 60 minutes (Figure 11, Figure 12, 0 nM Rev).  A 
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shortcoming to the depolymerization assay is that this percentage is too high based on 
assays completed with KinI proteins (Niederstrasser et al., 2002; Moores et al., 2002; 
Desai et al., 2001; personal communication, M. Miller).  A more acceptable percentage 
would be around 10%. 
In addition to tubulin, Rev concentrations can also be confirmed during this assay 
by western blotting.  If the amount of Rev present in the supernatant is greater when Rev 
is mixed with MTs than with Rev alone, then an interaction of Rev with MTs in indicated 
due to the movement of Rev.  When Rev is used alone during the depolymerization 
assay, it remains predominately in the pellet at 10 and 20 minutes, approximately 23% 
and 30% in the supernatant respectively (Figure 13).  When 3 µM MT’s are added, the 
amount of Rev in the supernatant increases at 10 and 20 minutes, approximately 40% and 
62% in the supernatant respectively, with the latter being statistically significant (p=.037) 
(Figure 13).   
The optimal stoichiometry for MT depolymerization by Rev needed to be 
determined.  The MTs were always kept at 3 µM.  Figure 11 and 14 represents results 
from adding different concentrations of Rev for 10 and 20 minutes incubations at each 
concentration.  Differences in linear regressions for concentration dependence are not 
statistically significant (p=.389); however, there is a statistically significant difference in 
the linear regression for 10 and 20 minute treatments (p=.021) with more 
depolymerization at 20 minutes (Figure 11).  This trend could be present because MTs 
themselves depolymerize more over time and not because of the addition of Rev.  At  
equimolar amounts of Rev to tubulin (3000 nM Rev), Rev has been shown to produce 
ringed structures or intermediates (Watts et al., 2000).  The ability of these rings to spin 
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down into the pellet at the speed used in this assay could be presenting an additional 
problem.  This would represent depolymerized tubulin in the pellet instead of the 
supernatant as expected.     
To consider the time variable, MTs were incubated with 30, 300, and 3000 nM 
Rev for 10, 20, 40, and 60 minutes (Figure 12).  There is a statistically significant 
(p<.001) increase in depolymerization at increasing reaction time.  At 10 minutes, there is 
approximately 26% to 37% MT depolymerization over all Rev concentrations.  At 60 
minutes, the percentages increase to 48% to 68% depolymerization over all Rev 
concentrations.  At 10 minutes, the rate of MT depolymerization is approximately 3% per 
minute and at 60 minutes is approximately .9% per minute, indicating a decrease in the 
rate of depolymerization over time.   
Visual MT Binding Assay (Specific Aim 3) 
 Equivocal results in the depolymerization assays necessitated the visual MT 
binding assay next to determine if Rev is even binding MTs.  If Rev is depolymerizing 
MTs via a mechanism shared with KinI kinesins, then it is hypothesized that Rev will 
preferentially bind the ends of MTs to depolymerize them.  To test this hypothesis, the 
visual MT binding assay was completed as described in Materials and Methods (Desai et 
al., 2001).  In brief, GMPcPP stabilized MTs are polymerized and diluted to 3 µM.  MTs 
and varying concentrations of Rev are mixed, incubated, and then fixed.  The reaction 
mixtures are then spun down onto coverslips and immunostained for the presence of Rev 
and tubulin. 
 Rev alone and MTs alone were spun down onto coverslips initially because the 
immunostaining conditions for Rev and MTs had to be optimized.  Rev spun down 
 
 29
uniformly onto the coverslips; however, MTs did not (data not shown).  There were small 
MT subunits all over the coverslip, but no MTs of measurable length.  To confirm the 
presence of MTs, a small aliquot of the reaction mixture was spotted onto coverslips for 
immunostaining, which indicated that the difficulty with this assay lies with the MTs.  
The rest of the assay was completed with the alternative method as described in 
“Materials and Methods.”  
In addition to observing Rev and MT colocalization for the visual MT binding 
assay, the length of MTs were measured at different times to determine if MT length was 
shortening, demonstrating MT depolymerization (Figure 15).  The MT length was 
measured for over 130 different MTs after 5 minutes incubation and then 60 minutes 
incubation for MTs alone and MTs mixed with equimolar amounts of Rev (3 µM).  As 
indicated in Figure 16, there is a greater decrease in the average length of MTs when 
mixed with Rev for 60 minutes than for 5 minutes.  Also noted is a qualitative result of 
more densely packed MTs at 5 minutes than at 60 minutes for MTs alone and MTs mixed 
with Rev (Figure 16).  It is unclear whether this is subject to handling error in the 
experiment, or indicative of the inability of the MTs to remain stable over the 60 minute 
reaction time. 
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Discussion 
Protein Purification (Specific Aim 1 & 2) 
 This study attempted to develop strategies to purify wild type and mutant Rev 
proteins and then use these proteins to develop assays that would measure their abilities 
to bind and depolymerize MTs.  Two published methods were successful in purifying 
wild type Rev protein, but to different degrees of purity.  Wild-type Rev appears as a 
single band on coomassie-stained SDS-PAGE gels using Method 1.  This method appears 
more useful for purifying wild type Rev protein.  Method 2 proved more useful in 
purifying mutant Rev proteins, although contaminating proteins are more prevalent.  It is 
unlikely these contaminating proteins affect MT polymerization; however, conditions for 
preparing suitable controls for these contaminants were identified so that MT 
depolymerization and visual MT binding assays could be used (Figure 9).  A buffer 
control should suffice for wild-type Rev purified by Method 1.  Rev R42A purified by 
Method 1 will require a negative control by passing BL21 E.coli cellular proteins over 
the Q-sepharose and Heparin-sepharose columns as described by Method 1.  If proteins 
after the Heparin-sepharose column fall below detection on coomassie-stained SDS-
PAGE, then proteins present in the bound fractions from the Q-sepharose column can be 
used.   
 Method 1 was used to purify traditional mutant M7 (data not shown).  Brice et al. 
(1999) also used this method to purify M7 and M4.  Rev E57A, which lays one amino 
acid after M7, theoretically should purify with Method 1, also.  However, this mutant, 
along with R39A and A37D, would not.  Rev E57A is in a region of the protein that is 
considered important for protein folding (Brice et al., 1999).  This mutation may disrupt 
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the conformation of Rev and not allow the arginine rich residues important for Method 1 
purification to be exposed (Brice et al., 1999).  It will be important that the activity of this 
mutant purified by Method 2 be accessed before it is used in assays. 
There are procedural changes that may improve purification of mutant proteins, 
including changing the salt concentration of the flow-through from the Q-sepharose 
column of Method 2 (0 mM NaCl) to equal that of the eluate of the Q-sepharose column 
of Method 1 (800 mM NaCl).  Raising the salt concentration of the solution before 
subjecting it to the Heparin column would allow more contaminating proteins to flow 
through instead of binding the column.  Method 2 buffer F contains no salt.  Method 1 
buffer B contains approximately 800 mM NaCl.  Method 1 purification works more 
efficiently and without as many protein contaminants.  If the flow through from Method 2 
is brought to 800 mM NaCl before subjected to the Heparin-sepharose column, to be 
similar to that of the eluate in Method 1, then the Heparin-column may run more 
effectively.  It may also prove beneficial to use a gradient elution versus a step elution 
when attempting to purify mutants with Method 1.  This would allow a slower increase in 
salt concentration and may provide fractions that contain mutant Rev with less protein 
contaminants. 
MT Depolymerization Assay (Specific Aim 3) 
 To test the hypothesis that Rev depolymerizes MTs in a mechanism similar to that 
of KinI Kinesins two assays were developed following KinI methods and not those 
provided by Watts et al. (2000).  The first assay focuses on wild-type and mutant Rev’s 
ability to depolymerize MTs.  This assay tests whether Rev can depolymerize MTs.  The 
long-term goal is to compare mutant with wild-type Rev protein.   
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 The first step was to use wild type Rev in this assay to have a comparison for the 
mutants.  During the assay, Rev predominately stayed in the pelleted fraction when it was 
assayed alone.  The location of Rev alone is important because it will be used as a 
comparison when MTs are added to the reaction mixture.  Upon the addition of MTs, 
more Rev shifted to the supernatant fractions.  This initial finding was the first evidence 
that Rev is binding and interacting with MTs. 
 At 3 µM MTs, 20-50 percent of the tubulin was in the supernatant fractions.  
GMP-cPP stabilized MTs are supposed to be in the pelleted fraction and remain there 
over time because GMP-cPP is a non-hydrolyzable form of GTP.  The depolymerization 
of GMP-cPP stabilized MTs requires multiple rounds of action, and is useful to analyze 
the reaction mechanism (Desai et al., 2001).  There is a small percentage (10-20%) of 
tubulin expected to be in the supernatant at approximately the same amount over time 
(Desai et al., 2001; Moores et al., 2002; Niederstrasser et al., 2002; personal 
communication, M. Miller).  There were increasing amounts of tubulin (20-50 percent) in 
the supernatant over time.  This indicates that the MTs are depolymerizing on their own; 
therefore, the increase in tubulin in the supernatant cannot be solely attributed to Rev 
depolymerizing MTs.  A possible explanation for tubulin depolymerizing on its own is 
that the tubulin used in the assay was not recycled.  Tubulin needs to be cycled to ensure 
that only active tubulin is being used in the assay.   
   When MTs and Rev were mixed, the concentration of Rev and the time of the 
reaction had to be measured as experimental variables.  It was evident early on that there 
was a time dependency for MT depolymerization (Figure 11, 12).  However, there was 
little evidence of a Rev concentration dependence.  The later finding was surprising.  To 
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solve the problem of MTs depolymerizing on their own, more stable MTs need to be 
prepared using taxol plus GMP-cPP and a higher starting concentration of recycled 
tubulin.  Taxol is another stabilizer of MTs that works by eliminating the GTP hydrolysis 
destabilization of tubulin (Desai et al., 2001).     
The MT depolymerization assay indicated that there is an increasing trend for 
wild-type Rev to depolymerize more MTs over time, but the critical concentration that is 
needed of Rev to depolymerize MTs cannot be determined (Figures 11 and 12).  This 
concentration will need to be determined in order to increase the efficiency of the assays.  
If the mutants indicate a similar graded result of more MT depolymerization over time 
and there is no critical concentration determined, then there is no sensitivity to the assay. 
 A potential shortcoming in the depolymerization assay is that the ringed 
intermediates may pellet, which would indicate depolymerized tubulin in what we are 
considering polymerized tubulin.  The rings are approximately 3.8 MDa with a diameter 
of approximately 40 nm (Watts et al., 2000). 
 There has been recent improvement of the depolymerization assay that has proven 
useful (personal communication, A. Sharma).  A protocol based on Watts et al. (2000) 
has been implemented using MES buffer with Rev and MEM buffer with MTs instead of 
dialysis buffer 3 and BRB80, and a higher concentration (20 µM instead of 3 µM) of Rev 
and MTs.  It is known that citrate (present in dialysis buffer 3) chelates Mg2+ ions 
(needed for MT polymerization).  Using the MEM/MES buffering system and higher 
concentrations of proteins has provided reproducible results with the depolymerization 
assay indicating that wild type Rev is depolymerizing MTs. 
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Visual MT Binding Assay (Specific Aim 3) 
 A visual MT binding assay was used to address the hypothesis that Rev binds the 
ends of MTs to depolymerize them.  However, it also produces a means for visually 
confirming MT length as a function of Rev activity.  While end binding is addressed, 
depolymerization of MTs can also be measured during this assay.   
 End binding was addressed by visualizing colocalization of Rev on the MT.  MTs 
were immunostained red and Rev immunostained green, colocalization was indicated by 
a yellow color, the combining of the two.  Yellow ends of MTs were noted (data not 
shown), indicating preferential end binding.  There were also many instances where the 
entire MT was decorated with Rev, or colored yellow.  This later finding could be a result 
of the high concentration of Rev used, along with the fact that the MTs were not spun 
down onto the coverslip, but instead were aliquoted directly to the coverslip.  Directly 
aliquoting the reaction onto the coverslip makes the background much higher and 
immunostaining more difficult.    
 The MTs were spotted alone, then MTs incubated with varying amounts of Rev 
for 5-60 minutes were spotted and MTs under each condition measured.  There was a 
greater decrease in length of MTs treated with Rev at 60 minutes than at 5 minutes, 
implying a time dependence of the depolymerization activity of Rev.  There was a 
noticeable trend in the number of MTs present in the Rev treated reactions.  At 60 
minutes there were only a fraction of the number of MTs present at 5 minutes.  This trend 
was present for MTs alone, also, which presents a problem with the finding with the Rev 
treated reactions.  The MTs are obviously not stable over the 60 minute time period used.  
 
 35
Using GMP-cPP and taxol, doubly stabilized MTs may allow MTs to be stable long 
enough for the assays to be completed. 
 There are shortcomings to this assay.  It is important to develop a way to spin the 
reaction mixtures down in order to eliminate small particles that can contribute to 
aesthetics of the coverslip (Hertzer et al., 2006; Desai et al., 2001).  Using the 
MEM/MES buffers in this assay may provide useful as BRB80 is present so the problem 
still exists with citrate (dialysis buffer 3) chelating Mg 2+ (BRB80).  Also, the length of 
the MTs used needs to be increased by increasing the concentration of tubulin during the 
polymerization step.  Lengthening MTs may contribute to more reliable measurements of 
MT length and allow MTs to be measured over a longer period of depolymerization time.  
Also, using taxol and/or taxol plus GMP-cPP stabilized MTs may make the MTs stay 
intact and spin down onto the coverslip because the taxol and GMP-cPP inhibit the 
hydrolysis of GTP and promotes MT polymerization. 
 Taken together, these two assays have indicated that there is an increasing trend in 
MT depolymerization by Rev over time, although this is clouded by the observation that 
MTs alone shorten with time.  This result was confirmed in both assays.  There is a need 
for a higher starting recycled tubulin concentration for both assays in order to have active 
tubulin that will polymerize into longer MT’s and/or more stable MTs with taxol and/or 
taxol plus GMP-cPP.  The new MES/MEM buffering system needs to be continued and 
implemented in the visual MT binding assay, along with the higher protein 
concentrations (Watts et al., 2000).  It is also important to consider the functionality of 
purified Rev in these assays. 
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Activity of Rev 
Preliminary steps to test Rev activity relied on injecting purified wild-type Rev 
into the cytoplasm of frog oocytes.  If Rev is folded properly and active, once injected 
into the oocyte, it should readily localize to the nucleus.  Oocytes incubated for 0 to 6 
hours to overnight after injection were placed in TCA to fix the proteins, and the nucleus 
was removed.  The nucleus and cytoplasmic portions were combined and then resolved 
by SDS-PAGE and western blotted for Rev.  No Rev was detected on any of the blots.  
Potential reasons for this outcome include Rev adhering to the injection needle and not 
being injected into the egg.  To solve this problem, the needle can be blocked with BSA 
prior to the experiment to stop any non-specific binding by Rev to the glass.  
Alternatively, Rev was degraded upon entry into the oocyte.  This seems unlikely 
because oocytes are designed for storage of proteins for use after fertilization, not to 
degrade them, unless Rev is not folded well.  Another means of confirming Rev activity 
is clearly required.  A potential assay is the transfection of Rev into Hela cells followed 
by immunostaining.  If Rev is folded properly and active, it should localize to the nucleus 
of the Hela cells.  Another way to assess functionality of Rev is to do a gel retardation 
assay to determine if Rev is binding the RRE and multimerizing (Brice et al., 1999; 
Thomas et al., 1998).  If Rev is not folded properly or is inactive, then the purification 
and/or dialysis method will have to be altered to promote proper folding of Rev.   
Hypothesis Revisited 
 I hypothesized that Rev is depolymerizing MTs in a shared mechanism with KinI 
Kinesins.  Rev could be binding the end of the MT, multimerizing along the length of the 
MT, causing a bent conformation in the MT, and subsequently causing depolymerization.  
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The residues important to Rev function were not studied (mutations), however, the 
initial/optimization experiments with wild-type Rev were completed.  The mentioned 
hypothesis is still unanswered, but there are reliable methods for protein purification of 
wild type and mutant Rev and tubulin.  Initial work with the MT depolymerization and 
visual MT binding assays has also been completed.  Early studies indicate that Rev is 
interacting with MTs and there is a trend in MT depolymerization in a time dependent 
manner.  These results are clouded by the tendency of the MTs to depolymerize on their 
own, for which corrective measures have been discussed including the use of MES/MEM 
buffers (Watts et al., 2000).  The initial results are consistent with the hypothesis by 
Watts et al. (2000) that Rev is binding and depolymerizing MTs.  The future work with 
mutants in this project will provide information into the mechanism by which Rev is 
depolymerizing MTs. 
Mechanistic and structural information about Rev and KinI’s ability to 
depolymerize MTs may be useful in the future study for treatments for HIV/AIDS and 
cancer.  Since MT polymerization and depolymerization are necessary events for cellular 
division, a MT depolymerizing agent (peptides derived from Rev) may be used to alter 
cell division.  This technology would be useful in the treatment of cancer where 
uncontrolled cell growth is the problem, and HIV where stopping infected cells from 
multiplying is imperative.  Tubulin derivatives may be designed to interact with Rev and 
detour Rev into unproductive reactions.  This data will also be useful to provide structural 
information about Rev protein. 
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Table 1: Comparison of HIV-1 Rev and KinI Kinesin Characteristics   
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Characteristics 
 
HIV-1 Rev KinI Kinesins 
Sequence homology with  
 
 
KinI’s Rev 
Multimerization required for depolymerization 
of MTs 
 
Unknown No 
Depolymerizes MTs forming rings 
 
 
Yes Yes 
ATPase activity 
 
 
No Yes (not required 
for MT 
depolymerization) 
Depolymerize subtilisin-treated MTs 
 
 
Yes No 
Depolymerize from end of MT Yes 
 
 
Yes 
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Figure 1: HIV-1 Rev mutant amino acid sequences and diagram.  (A) Traditional Rev 
mutants (red), and Rev:XKCM1 homology mutants (black) sequences.  The positions of 
the mutants are below the sequence and how the sequences are changed listed above.  
The XKCM1 homology mutants are named by their substitution listed on the top of the 
sequence.  (B) Schematic diagram of Rev domains with Rev:XKCM1 point mutations on 
top and traditional mutations on bottom. 
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Figure 2:  Rev and KinI Kinesin Sequence Alignments  Amino acid alignment of Rev, 
XKCM1, Kif2c.  For XKCM1 and Kif2c residues identical to Rev are indicated in red, 
conservative substitutions in green, and similar substitutions in blue.  The sequence 
alignment of Kif1A, a motile kinesin, is shown for comparison. 
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REV     34        TRQARRNRRRRWRERQRQIHSISERILSTYLGRSAEP          
XKCM1   500 NERGVDTASADRITRMEGAEINRSLLALKECIRALGQNKSHTPFRESKLTQ     
Kif2c   492 NERGADTSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTPFRESKLTQ 
 
Kif1A   252 SERADSTGAKGTRLKEGANINKSLTTLGKVISALAEMDSGPNKNKKKKTDF 
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Figure 3: Structure of Kif2c with Rev Homology Domain  (A) The structure of Kif2c 
in ADP bound state (PDB, 1V8J).  (B)The structure of Kif2c in AMP-PNP bound state 
(PDB, 1V8K).  The Rev homology domain is highlighted in cyan, and residues are 
colored to match the XKCM1 homology, identical residues are red, conservative 
substitutions are green and similar substitutions are blue.  Kif2c residues and loops are 
labeled for orientation.  Amino acids 498, 501, 503, 506 (B only), and 534 are not present 
in the structure of Kif2c. 
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Figure 4: Method 1 Purification of WT Rev  Sonicates clarified by 10,000 x g were 
subjected to sequential Q-sepharose (A) and Heparin-sepharose (C) columns as described 
in Materials and Methods, x-axis represents milliliters of buffer (ml) and y-axis 
represents milli absorbance units (mAU).  Representative fractions for each column were 
resolved by SDS-PAGE (B,D).  Rev protein (10 µg) was re-folded by sequential dialysis 
steps as described in Materials and Methods (E) and resolved by SDS-PAGE.   
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Figure 5: Method 1 Purification of R42A  Sonicates clarified by 10,000 x g were 
subjected to sequential Q-sepharose (A) and Heparin-sepharose (C) columns as described 
in Materials and Methods, x-axis represents milliliters of buffer (ml) and y-axis 
represents milli absorbance units (mAU).  Representative fractions for each column were 
resolved by SDS-PAGE (B,D).  R42A Rev protein was re-folded by sequential dialysis 
steps as described in Materials and Methods (E) and resolved by SDS-PAGE. 
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Figure 6: Attempted Purification of Rev R39A Using Method 1   Sonicates clarified 
by 10,000 x g were subjected to sequential Q-sepharose (A) column as described in 
Materials and Methods, x-axis represents milliliters of buffer (ml) and y-axis represents 
milli absorbance units (mAU).  Representative fractions were resolved by SDS-PAGE 
(B).   
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Figure 7: Method 2 Purification of WT Rev  Sonicates clarified by 10,000 x g were 
subjected to sequential Q-sepharose (A) and Heparin-sepharose (C) columns as described 
in Materials and Methods, x-axis represents milliliters of buffer (ml) and y-axis 
represents milli absorbance units (mAU).  Representative fractions for each column were 
resolved by SDS-PAGE (B,D).   
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Figure 8: Method 2 Purification of E57A  Sonicates clarified by 10,000 x g were 
subjected to sequential Q-sepharose (A) and Heparin-sepharose (C) columns as described 
in Materials and Methods, x-axis represents milliliters of buffer (ml) and y-axis 
represents milli absorbance units (mAU).  Representative fractions for each column were 
dot blotted (B) and resolved by SDS-PAGE (D).  E57A Rev protein was re-folded by 
sequential dialysis steps as described in Materials and Methods (E) and resolved by SDS-
PAGE. 
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Figure 9: Negative Control Purification Method 2  10 µl protein sample purified by 
Method 2.  Sample taken from end of Q-sepharose column (BL21 cells only).  Contains 
Method 2 contaminating proteins and no Rev.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      181   *  
       
 
      82     *
 
       
      48     *
 
 
 
 
      25     *
 
 
      14     *
kDa 
 
 62
Figure 10: Purified Bovine Tubulin Protein  Purified bovine tubulin resolved by 
coomasie stained SDS-PAGE.  Tubulin is a 55 kDa protein.  Lane 1 contains 1.56 µg 
tubulin, and lane 2 contains 4.68 µg tubulin.   
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Figure 11: Depolymerization of Tubulin as a Function of Rev Concentration  Green 
diamonds indicate 10 minute incubation and red squares indicate 20 minute incubation of 
Rev with MTs.  X-axis indicates log of nanomolar concentration of Rev mixed with 3 
µM MT’s.  The y-axis depicts the percentage of tubulin released into the supernatant, 
indicative of MT depolymerization.  Averages and standard deviations computed on 3 
independent experiments for 10 nM, 80 nM, 100 nM, and 800 nM Rev at 10 and 20 
minutes.  Averages and standard deviations computed on 7 independent experiments at 
30 nM and 300 nM Rev, 8 independent experiments at 3000 nM Rev at 10 and 20 
minutes, and 9 independent experiments at 0 nM Rev at 10 and 20 minutes. 
 
Equation for Green Line: y = .0022x + 22.3     R2 = .0513 
Equation for Red Line: y = .0002x + 36.0       R2 = .0011 
 
Analysis of variance indicates that differences in linear regressions for concentration 
dependence are not statistically significant (p=.389).  However, analysis of variance 
indicates that differences in linear regressions for 10 and 20 minute time points are 
statistically significant (p=.021), and this is confirmed by one-way ANOVA between 10 
and 20 minute data points which show statistically significant differences (p=.008).  
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Figure 12: Depolymerization of MT’s by Rev Over Time  Blue diamonds indicate 0 
nM Rev incubation, pink squares indicate 30 nM Rev incubation, green triangles indicate 
300 nM Rev incubation, red x’s indicate 3000 nM Rev incubation.  X-axis indicates time 
(min) Rev mixed with 3 µM MTs, and y-axis indicates % of tubulin released into the 
supernatant (indicative of MT depolymerization).  Averages and standard deviations 
computed on 7 independent experiments at 30 nM and 300 nM Rev at 10 and 20 minutes, 
and 3 independent experiments at 40 and 60 minutes.  Averages and standard deviations 
computed on 8 independent experiments at 3000 nM Rev at 10 and 20 minutes and 3 
independent experiments at 40 and 60 minutes.  Averages and standard deviations 
computed on 9 independent experiments at 0 nM Rev at 10, 20, 40, and 60 minutes. 
 
Equation of Blue Line: y = .262x + 29.5     R2 = .420 
Equation of Pink Line: y = .630x + 21.1     R2 = .736 
Equation of Green Line: y = .837x + 22.4     R2 = .853 
Equation of Red Line: y = .288x + 34.4     R2 = .274 
 
Analysis of variance indicates that differences in linear regressions for concentration 
dependence are not statistically significant (p=.686).  However, analysis of variance 
indicates that differences in linear regressions for time dependence are statistically 
significant (p<.001), and this is confirmed by two-way ANOVA between 10, 20, 40, and 
60 minute data points which show statistically significant differences (p=.009). 
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Figure 13: Amount of Rev Released into 90,000 rpm Supernatant  Blue bars indicate 
3 µM Rev alone.  Red bars indicate 3 µM Rev mixed with 3 µM MTs.  X-axis indicates 
time in minutes and y-axis indicates percentage of Rev present in the supernatant. 
Averages and standard error of the mean computed on 3 independent experiments at 10 
minutes and 2 at 20 minutes for Rev alone (blue bars).  Averages and standard deviation 
computed on 4 independent experiments at 10 and 20 minutes for Rev and MTs (red 
bars).   
 
There is no statistically significant difference in the amount of Rev in the supernatant 
with the addition of MTs at the 10 minute time period (p=.388), however statistically 
significant differences are noted at the 20 minute time period (p=.037). 
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Figure 14: Coomasie stained SDS-PAGE gels of MT Depolymerization Assay  
Representative gels from MT depolymerization assay as described in Materials and 
Methods.  Each lane contains 10 µl of reaction mixture.  All lanes except 3 and 4 (gel 1); 
and 1 and 2 (gel 3) contain 3 µM MT’s plus the amount of Rev indicated above the lane 
number.  All Gel 1 lanes and Gel 2 lanes 1-8 are after 10 minutes.  Gel 2 lanes 9-10 and 
all gel 3 and 4 lanes are after 20 minutes.  Lanes 7-10 on gel 4 are blank.  (S = 
supernatant; P = pellet)   
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Figure 15: MTs Spotted on Coverslip  (A) MTs incubated with 300 nM Rev for 10 
minutes, fixed, and spotted on a coverslip.  MTs are visible and measurable.  MTs are 
red, Rev is green, and colocalization of Rev and MTs is yellow.  Similar pictures were 
obtained for 30 and 3000 nM Rev with MTs.  (B) MTs alone, fixed, and spotted on a 
coverslip.  Bar 1.78 µm. 
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Figure 16: MT Depolymerization by Visual MT Binding Assay  (A) MT length 
measured during visual MT binding assay.  Red bars are 3 µM MTs alone.  Yellow bars 
are equimolar amounts of Rev and MTs (3 µM).  At least 130 MTs randomly measured at 
each time point to determine averages and standard deviation.  (B-E) Representative 
pictures of each reaction mixture with total number of measured MTs listed above.  MTs 
are red, and the measurements are multicolored lines with numbers next to them.  (B) 5 
minutes MT, (C) 60 minutes MT, (D) 5 minutes MT + Rev, (E) 60 minutes MT + Rev.  
Bar =1.78 µm. 
 
No statistical significance (p>.05) 
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(B)  43 measured MTs 
 
 
 
(C)  11 measured MTs 
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(D) 36 measured MTs 
 
 
 
(E) 11 measured MTs 
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